FDA Issues Warning Letter to Microvascular Tissue
December 17, 2025
December 17, 2025
WASHINGTON, Dec. 17 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Microvascular Tissue Inc. from the Center for Biologics Evaluation and Research:
* * *
Recipient: Glen G. Gong, PhD, Chief Executive Officer, Microvascular Tissue, Inc., 6199 Cornerstone Court East, Suite 109, San Diego, CA 92121, United States, ggong@mvtissues.com
Issuing Office: Center for Biologics Evaluation and Re . . .
* * *
Recipient: Glen G. Gong, PhD, Chief Executive Officer, Microvascular Tissue, Inc., 6199 Cornerstone Court East, Suite 109, San Diego, CA 92121, United States, ggong@mvtissues.com
Issuing Office: Center for Biologics Evaluation and Re . . .